|
EC 3.4.21.36 (pancreatic elastase) inhibitor
|
CHEBI_149639 |
|
|
Mycobacterium tuberculosis
|
NCBITaxon_1773 |
|
|
SU-DHL-10 cell
|
CLO_0037059 |
|
|
multiple system atrophy
|
DOID_4752 |
|
|
synucleinopathy
|
DOID_0050890 |
|
|
striatonigral degeneration
|
DOID_4751 |
|
|
partial prostacyclin agonist
|
CHEBI_51577 |
|
|
vasodilator agent
|
CHEBI_35620 |
|
|
anticoagulant
|
CHEBI_50249 |
|
|
allelochemical
|
CHEBI_62215 |
|
|
Keshan disease
|
DOID_0050083 |
|
|
pulmonary blastoma
|
DOID_4765 |
|
|
myotonia congenita
|
DOID_2106 |
|
|
laryngitis
|
DOID_3437 |
|
|
laryngeal disease
|
DOID_786 |
|
|
pleuropulmonary blastoma
|
DOID_4769 |
|
|
EC 6.3.5.3 (phosphoribosylformylglycinamidine synthase) inhibitor
|
CHEBI_138927 |
|
|
EC 6.3.5.* (carbon-nitrogen ligases with glutamine as amido-N-donor) inhibitor
|
CHEBI_138920 |
|
|
EC 6.3.5.2 [GMP synthase (glutamine-hydrolysing)] inhibitor
|
CHEBI_138928 |
|
|
somatoform disorder
|
DOID_4737 |
|
